Radical prostatectomy in obese patients
Wednesday, June 30th, 2010 Posted in prostate cancer risks, prostatectomy | No Comments »Previous studies have reported obesity as a risk factor for reduced disease-specific survival, increased positive surgical margin (PSM) and biochemical recurrence (BCR) after radical prostatectomy (RP) in patients with prostate cancer. A recent study at University of Toronto, Canada, aimed to ...
Statins associated with lower cancer recurrence following prostatectomy
Tuesday, June 29th, 2010 Posted in prostatectomy | No Comments »According to researchers at Duke University Medical Center., men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs. Researchers ...
The predictive value of stage, grade and PSA for recurrence after radical prostatectomy as a function of surgeon experience
Monday, June 28th, 2010 Posted in prostatectomy | No Comments »In a new analysis of their database of over 8,000 patients treated at three major prostate cancer centers, a sientific team at Memorial Sloan-Kettering Cancer Center, has now investigated the association between biological predictors of progression (stage, Gleason grade and ...
Dietary administration of mushroom mycelium extracts in patients with early stage prostate cancers managed expectantly might be ineffective
Sunday, June 27th, 2010 Posted in alternative treatments | No Comments »A recent study at Shikoku Cancer Center, Matsuyama, Japan, aimed to assess the efficacy and safety of mushroom dietary supplements in patients with early stage prostate cancers who are managed expectantly. In this phase II, the study concluded that a mushroom ...
Study shows monitoring can be the best treatment for men with prostate cancer of low-risk type
Saturday, June 26th, 2010 Posted in watchful waiting | No Comments »According to a study now being published in the Journal of the National Cancer Institute, monitoring can be the best treatment for men with prostate cancer of the low-risk type. How local prostate cancer, that is, cancer that has not spread ...
PARP inhibitors may help men with prostate cancer due to BRCA2 alteration
Friday, June 25th, 2010 Posted in prostate cancer | No Comments »A study recently published in PLoS Genetics reveals the way prostate cancer develops in men who have an altered 'breast cancer gene' is the same route by which breast cancer develops in women with the same mutation. Alterations in the gene ...
Optimum radiation dose on same day as brachytherapy implant can control prostate cancer
Thursday, June 24th, 2010 Posted in radiation therapy | No Comments »A new research undertaken at the University Hospital of Navarre concludrd ensuring the optimum radiation dose on the same day as the brachytherapy implant in prostate cancer treatment manages to control the illness in about 95% of the cases. The results ...
Cryo surgery - New prostate cancer treatment
Wednesday, June 23rd, 2010 Posted in prostate cryotherapy | No Comments »A new surgical procedure, known al cryo surgery, freezes prostate cancer. Many studies suggest cryo surgery drastically cuts recovery time. This procedure is basically done as an outpatient procedure. These patients who choose to undergo cryoblation are put under anesthesia, then ...
Exposure to banned environmental estrogen increases risk of prostate cancer
Tuesday, June 22nd, 2010 Posted in prostate cancer risks | No Comments »From 1973 to 1993 the estrogenic insecticide chlordecone (marketed as Kepone) was widely used in the French West Indies to control pests in the banana crop. In the USA it was once used to bait household insect traps. A new study investigated ...
Watchful Waiting often best strategy for slow-progressing prostate cancer
Monday, June 21st, 2010 Posted in Uncategorized | No Comments »According to a large-scale study from Sweden, for patients with prostate cancer that has a low risk of development, watchful waiting, also known as "active surveillance," may be a suitable treatment option, . The issue of how (or whether) to treat ...